Clinical Trial: Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07123467) titled 'Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder' on Aug. 02.

Brief Summary: This randomized, double-blind, placebo-controlled clinical trial investigates the use of Food and Drug Administration (FDA)-approved cannabidiol (EPIDIOLEX(R)) as an adjunct to cognitive behavioral therapy (CBT) in adults with generalized anxiety disorder (GAD). The study aims to evaluate whether cannabidiol-assisted CBT enhances emotion regulation via dorsomedial prefrontal cortex (dmPFC) activation and improves anxiety symptom outcomes compared to CBT with placebo.

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: ...